| A survey on security and privacy of 5G technologies: Potential solutions, recent advancements, and future directions R Khan, P Kumar, DNK Jayakody, M Liyanage IEEE Communications Surveys & Tutorials 22 (1), 196-248, 2019 | 388 | 2019 |
| Role of salivary biomarkers in oral cancer detection Z Khurshid, MS Zafar, RS Khan, S Najeeb, PD Slowey, IU Rehman Advances in clinical chemistry 86, 23-70, 2018 | 215 | 2018 |
| Transformational leadership and organizational innovation: Moderated by organizational size R Khan, AU Rehman, A Fatima African Journal of Business Management 3 (11), 678, 2009 | 190 | 2009 |
| Salivary IL-8, IL-6 and TNF-α as potential diagnostic biomarkers for oral cancer HA Sahibzada, Z Khurshid, R Sannam Khan, M Naseem, ... Diagnostics 7 (2), 21, 2017 | 145 | 2017 |
| Advancing point-of-care (PoC) testing using human saliva as liquid biopsy RS Khan, Z Khurshid, F Yahya Ibrahim Asiri Diagnostics 7 (3), 39, 2017 | 110 | 2017 |
| Phase I Trial of a Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Advanced MalignanciesPhase I Trial of Sorafenib and … DS Hong, SM Sebti, RA Newman, MA Blaskovich, L Ye, RF Gagel, ... Clinical Cancer Research 15 (22), 7061-7068, 2009 | 92 | 2009 |
| Investing in medication adherence improves health outcomes and health system efficiency: adherence to medicines for diabetes, hypertension, and hyperlipidaemia R Khan, K Socha-Dietrich OECD, 2018 | 88 | 2018 |
| First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors DS Hong, H Henary, GS Falchook, A Naing, S Fu, S Moulder, JJ Wheler, ... Investigational new drugs 32, 1204-1212, 2014 | 73 | 2014 |
| Role of salivary biomarkers in detection of cardiovascular diseases (CVD) S Abdul Rehman, Z Khurshid, F Hussain Niazi, M Naseem, H Al Waddani, ... Proteomes 5 (3), 21, 2017 | 64 | 2017 |
| Neighbourhood safety and area deprivation modify the associations between parkland and psychological distress in Sydney, Australia S Chong, E Lobb, R Khan, H Abu-Rayya, R Byun, B Jalaludin BMC public health 13 (1), 1-8, 2013 | 56 | 2013 |
| Advances of salivary proteomics in oral squamous cell carcinoma (OSCC) detection: an update R Sannam Khan, Z Khurshid, S Akhbar, S Faraz Moin Proteomes 4 (4), 41, 2016 | 54 | 2016 |
| Human oral defensins antimicrobial peptides: a future promising antimicrobial drug Z Khurshid, MS Zafar, M Naseem, RS Khan, S Najeeb Current pharmaceutical design 24 (10), 1130-1137, 2018 | 50 | 2018 |
| Significance and diagnostic role of antimicrobial cathelicidins (LL-37) peptides in oral health Z Khurshid, M Naseem, F Yahya I. Asiri, M Mali, R Sannam Khan, ... Biomolecules 7 (4), 80, 2017 | 43 | 2017 |
| Bisphosphonate releasing dental implant surface coatings and osseointegration: A systematic review S Najeeb, MS Zafar, Z Khurshid, S Zohaib, SM Hasan, RS Khan Journal of Taibah University Medical Sciences 12 (5), 369-375, 2017 | 36 | 2017 |
| First-in-human study of AMG 337, a highly selective oral inhibitor of MET, in adult patients (pts) with advanced solid tumors. DS Hong, P LoRusso, O Hamid, DM Beaupre, F Janku, R Khan, ... Journal of Clinical Oncology 32 (15_suppl), 2508-2508, 2014 | 32 | 2014 |
| Novel SWIPT schemes for 5G wireless networks A Rajaram, R Khan, S Tharranetharan, DNK Jayakody, R Dinis, S Panic Sensors 19 (5), 1169, 2019 | 30 | 2019 |
| Human salivary protein extraction from RNAPro· SAL™, Pure· SAL™, and passive drooling method Z Khurshid, SF Moin, RS Khan, MAS Agwan, AH Alwadaani, MS Zafar European journal of dentistry 11 (03), 385-389, 2017 | 26 | 2017 |
| Prevalence of work related musculoskeletal disorders (MSD) among dentists R Khan, F Ahmad, MS Merchant Int J Contemp Med Res 483, 77-2393, 2017 | 26 | 2017 |
| Bioactive glasses and their applications in dentistry MD Khalid, MS Zafar, I Farooq, RS Khan, A Najmi JPDA 26 (01), 33, 2017 | 26 | 2017 |
| Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial KM Mullane, VA Morrison, LH Camacho, A Arvin, SA McNeil, J Durrand, ... The Lancet Infectious Diseases 19 (9), 1001-1012, 2019 | 22 | 2019 |
